NOW PLAYING
Presented by PhRMA{beacon}
Healthcare
Health Care PRESENTED BY

The Big Story
GOP bill leaves out anti-Planned Parenthood language
Anti-abortion lawmakers and advocates saw one of their main policy goals left by the wayside once again after a prohibition on Medicaid funding going to abortion providers like Planned Parenthood was not included in House Republicans’ reconciliation bill framework.

© AP Photo/Allen G. Breed
A one-year ban on abortion providers being able to bill Medicaid for non-abortion services, which was included in the GOP’s One Big Beautiful Bill Act that President Trump signed last year, expired on July 5.
Anti-abortion activists have for months been calling for such a provision to be included in another bill that could go through the same special budget reconciliation process that bypasses the threat of a Democratic filibuster in the Senate, allowing Republicans to push partisan legislation through both chambers.
“That’s a terrible decision on the part of House leadership,” Sen. Josh Hawley (R-Mo.) told The Hill. “I can’t wait to hear the explanation for that. But it’s absolutely terrible.”
Election year politics and a narrow congressional majority have made GOP leaders hesitant about including controversial anti-abortion measures into their recent party-line bills.
Lawmakers are entering a sprint to the mid-term elections with only a few dozen legislative days between now and November, meaning Republicans need to act quickly if they want any of their priorities to pass.
The dynamic threatens to exacerbate the tension between Republicans and anti-abortion activists, who were already expressing displeasure with the Trump administration for not doing enough to curtail mail-order abortion pills.
“The clock was our greatest threat to the broader opportunities,” House Budget Committee Chair Jodey Arrington (R-Texas) said. “Introduce that, then you’re going to have a whole set of moving parts.”
Anti-abortion activists and lawmakers are now hopeful the Trump administration will do more.
Acting Attorney General Todd Blanche in his Wednesday confirmation hearing pledged to prioritize action to stop abortion medication from being available through the mail, in an encouraging sign for anti-abortion advocates.
Two days later, Hawley sent Blanche a letter asking him to investigate the nonprofit Plan C and manufacturer Danco Laboratories for shipping the abortion pill mifepristone in the mail.
“This coordinated effort between Plan C and the abortion drug manufacturers to violate state law at the expense of women’s health deserves the closest scrutiny,” Hawley wrote.
Welcome to The Hill’s Healthcare newsletter, we’re Nathaniel Weixel and Joseph Choi — every week we follow the latest moves on how Washington impacts your health.
Did someone forward you this newsletter? Subscribe here.
The Hill Insider is coming
A new all-access digital subscription from The Hill — launching July 2026. Join the waitlist to be among the first inside
Join the waitlistEssential Reads
How policy will be impacting the healthcare sector this week and beyond:
Trump admin freezes over $1B in Medicaid funds for Minnesota, California
The Trump administration is pausing more than $1 billion in Medicaid payments to California and Minnesota over alleged fraud concerns, officials announced Tuesday. Tuesday marked the second time Trump targeted the two states’ Democratic governors — California Gov. Gavin Newsom and Minnesota Gov. Tim Walz — for alleged Medicaid fraud in their states, and continues a trend of freezing funding to blue states to crack …
Full Story
Upcoming FDA peptide meeting puts industry on edge
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s recently reformed committee on compounding pharmacies will meet this week to discuss adding more peptides to the list of substances that pharmacies can produce. But industry observers are conflicted over treating peptides — which Kennedy has said he’s a “big fan of” — like pharmaceuticals. The Pharmacy Compounding Advisory Committee (PCAC) …
Full Story
Novo Nordisk sues rival Eli Lilly over weight loss drug advertising
Drugmaker Novo Nordisk sued rival Eli Lilly on Tuesday, accusing the company of false advertising over the performance of its weight loss drugs. The lawsuit, filed in federal district court in New Jersey, alleges Lilly intentionally selected outdated studies to show the use of Mounjaro and Zepbound lead to significantly more weight loss than Novo Nordisk’s Ozempic and Wegovy. The studies compared higher doses of Lilly’s medicine …
Full Story
On Our Radar
Upcoming news themes and events we’re watching:
- The Senate HELP Committee will debate and vote on a host of bipartisan health bills Wednesday, including legislation on insulin pricing
Americans get new medicines 3 years faster than other high-income countries thanks to our biopharmaceutical leadership. If Washington copies other countries’ price control policies, we risk America’s access to cures. Learn more
In Other News
Branch out with a different read from The Hill:

Heavy smoke from wildfires blankets the US Midwest and Northeast, prompting evacuations
Thousands of visitors were told to evacuate a remote Minnesota wilderness area accessible only by boat as wildfires send dangerously heavy smoke over the U.S. Midwest and Northeast this week. More than 100 wildfires are burning in Canada, where a train crew in northern Ontario filmed themselves surrounded by flames before being safely …
Full StoryAround the Nation
Local and state headlines on healthcare:
- A Deloitte-run system denied Medicaid benefits for Michigan’s disabled. Now Trump’s law piles on (KFF Health News)
- Faced with piles of new paperwork, Arizonans are losing food stamps (New York Times)
- Gov. Greg Abbott orders state health agencies to crack down on ‘birth tourism’ (Houston Public Radio)
What We’re Reading
Health news we’ve flagged from other outlets:
- Makers of rare disease drugs seek exemption from Trump’s price-cut pilots (Stat)
- They used GLP-1s to lose weight. They ended up in treatment for anorexia (Wall Street Journal)
- Fewer children got US-backed HIV treatment after aid cuts, study finds (Reuters)
What People Think
Opinions related to health submitted to The Hill:
- MAHA voters feel betrayed — Republicans proceed at their own risk
- Most of Congress backs this bill to support breast cancer patients. Why isn’t it law?
You’re all caught up.
Check out The Hill’s Healthcare page for the latest coverage.
Like this newsletter? Take a moment to view our other topical products here 📩
Privacy Policy | Manage Subscriptions | Unsubscribe
400 N Capitol Street NW Suite 650, Washington, DC 20001
Copyright © 1998 – 2026 Nexstar Media Inc. | All Rights Reserved.
If you believe this has been sent to you in error, please safely unsubscribe.
CloseThank you for signing up!
Subscribe to more newsletters here
The latest in politics and policy. Direct to your inbox. Sign up for the Health Care newsletter Subscribe Add as preferred source on Google TagsCopyright 2026 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Comments: Link copiedMore Healthcare Newsletter News
See All
Healthcare Newsletter FDA still focused on Taylor Farms amid cyclospora outbreak by Joseph Choi and Nathaniel Weixel 1 day ago Healthcare Newsletter / 1 day ago

